![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BAUSCH & LOMB COMPLETES ACQUISITION OF SHANDONG CHIA TAI FREDA PHARMACEUTICAL GROUP
BAUSCH & LOMB COMPLETES ACQUISITION OF SHANDONG CHIA TAI FREDA PHARMACEUTICAL GROUP
Bausch & Lomb (NYSE:BOL) has completed the previously announced acquisition of a controlling interest in Shandong Chia Tai Freda Pharmaceutical Group (CTF), the leading ophthalmic pharmaceutical company in China, from Sino Biopharmaceutical Ltd.(HKSE: 1177.HK) for $200 million in cash. The acquisition will accelerate Bausch & Lomb's expansion into the rapidly growing ophthalmic pharmaceuticals market in China and provide Bausch & Lomb with a national pharmaceuticals sales and distribution network, strong domestic brands, a GMP-certified manufacturing facility, and expertise in regulatory affairs and product development.
Finanzen.net (http://finanzen.net/news/news_detail.asp?NewsNr=337472)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct